RASSF1A and p16 promoter methylation and treatment response in chronic hepatitis C genotype 1b patients treated with pegylated interferon/ribavirin

RASSF1A and p16 promoter methylation and treatment response in chronic hepatitis C genotype 1b patients treated with pegylated interferon/ribavirin

Prevention of chronic hepatitis C (CHC) and its complications is based on antiviral therapy and early detection of reliable molecular markers in persons under risk. We investigated whether the methylation status of RASSF1A and p16 genes, alone or in combination with host and viral factors, affects t...

Full description

Bibliographic Details
Main Authors: Kokanov Nikola S., Krajnović Milena M., Ćupić-Jovanović Snežana P., Kožik Bojana R., Petrović Nina M., Božović Ana M., Mandušić Vesna Lj.
Format: Article
Language:English
Published: University of Belgrade, University of Novi Sad 2022-01-01
Series:Archives of Biological Sciences
Subjects:
hepatitis c virus
dna methylation
rassf1a
p16
biomarkers
Online Access:http://www.doiserbia.nb.rs/img/doi/0354-4664/2022/0354-46642200004K.pdf

Similar Items

Similar Items